世界の嚢胞性線維症（CF）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cystic Fibrosis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1697
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、131ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、嚢胞性線維症（CF）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CFTR、粘液溶解薬、PERT、抗感染薬、気管支拡張薬）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・嚢胞性線維症（CF）治療薬の市場動向
・企業の競争状況、市場シェア
・嚢胞性線維症（CF）治療薬の種類別市場規模（CFTR、粘液溶解薬、PERT、抗感染薬、気管支拡張薬）
・嚢胞性線維症（CF）治療薬の用途別市場規模（病院、クリニック）
・嚢胞性線維症（CF）治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・嚢胞性線維症（CF）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・嚢胞性線維症（CF）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・嚢胞性線維症（CF）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・嚢胞性線維症（CF）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Vertex Pharmaceuticals、F. Hoffmann-La Roche、AbbVie、Gilead Sciences、Novartis、AstraZeneca、Bayer、Celtaxsys、Pharmaxis、ProQR Therapeutics、PTC Therapeutics、Alcresta Therapeutics、Insmed Incorporated、Savara、Cyclacel Pharmaceuticals、Vectura、Allergan）
・結論

Market Analysis and Insights: Global Cystic Fibrosis Therapeutics Market
The global Cystic Fibrosis Therapeutics market size is projected to reach US$ 11170 million by 2026, from US$ 4551.4 million in 2019, at a CAGR of 13.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cystic Fibrosis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cystic Fibrosis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cystic Fibrosis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cystic Fibrosis Therapeutics market.

Global Cystic Fibrosis Therapeutics Scope and Market Size
Cystic Fibrosis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cystic Fibrosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
Gilead Sciences
Novartis
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CFTR
1.2.3 Mucolytics
1.2.4 PERT
1.2.5 Anti-infectives
1.2.6 Bronchodilators
1.3 Market by Application
1.3.1 Global Cystic Fibrosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cystic Fibrosis Therapeutics Market Perspective (2016-2027)
2.2 Cystic Fibrosis Therapeutics Growth Trends by Regions
2.2.1 Cystic Fibrosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cystic Fibrosis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Cystic Fibrosis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Cystic Fibrosis Therapeutics Industry Dynamic
2.3.1 Cystic Fibrosis Therapeutics Market Trends
2.3.2 Cystic Fibrosis Therapeutics Market Drivers
2.3.3 Cystic Fibrosis Therapeutics Market Challenges
2.3.4 Cystic Fibrosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue
3.1.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cystic Fibrosis Therapeutics Revenue
3.4 Global Cystic Fibrosis Therapeutics Market Concentration Ratio
3.4.1 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Therapeutics Revenue in 2020
3.5 Cystic Fibrosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Cystic Fibrosis Therapeutics Product Solution and Service
3.7 Date of Enter into Cystic Fibrosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cystic Fibrosis Therapeutics Breakdown Data by Type
4.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Cystic Fibrosis Therapeutics Breakdown Data by Application
5.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cystic Fibrosis Therapeutics Market Size (2016-2027)
6.2 North America Cystic Fibrosis Therapeutics Market Size by Type
6.2.1 North America Cystic Fibrosis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Cystic Fibrosis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Cystic Fibrosis Therapeutics Market Size by Type (2016-2027)
6.3 North America Cystic Fibrosis Therapeutics Market Size by Application
6.3.1 North America Cystic Fibrosis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Cystic Fibrosis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Cystic Fibrosis Therapeutics Market Size by Application (2016-2027)
6.4 North America Cystic Fibrosis Therapeutics Market Size by Country
6.4.1 North America Cystic Fibrosis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Cystic Fibrosis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cystic Fibrosis Therapeutics Market Size (2016-2027)
7.2 Europe Cystic Fibrosis Therapeutics Market Size by Type
7.2.1 Europe Cystic Fibrosis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Cystic Fibrosis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Cystic Fibrosis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Cystic Fibrosis Therapeutics Market Size by Application
7.3.1 Europe Cystic Fibrosis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Cystic Fibrosis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Cystic Fibrosis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Cystic Fibrosis Therapeutics Market Size by Country
7.4.1 Europe Cystic Fibrosis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Cystic Fibrosis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cystic Fibrosis Therapeutics Market Size (2016-2027)
9.2 Latin America Cystic Fibrosis Therapeutics Market Size by Type
9.2.1 Latin America Cystic Fibrosis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Cystic Fibrosis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Cystic Fibrosis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Cystic Fibrosis Therapeutics Market Size by Application
9.3.1 Latin America Cystic Fibrosis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Cystic Fibrosis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Cystic Fibrosis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Cystic Fibrosis Therapeutics Market Size by Country
9.4.1 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Details
11.1.2 Vertex Pharmaceuticals Business Overview
11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.1.5 Vertex Pharmaceuticals Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Cystic Fibrosis Therapeutics Introduction
11.3.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Introduction
11.4.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.4.5 Gilead Sciences Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Cystic Fibrosis Therapeutics Introduction
11.5.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Cystic Fibrosis Therapeutics Introduction
11.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Celtaxsys
11.8.1 Celtaxsys Company Details
11.8.2 Celtaxsys Business Overview
11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Introduction
11.8.4 Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.8.5 Celtaxsys Recent Development
11.9 Pharmaxis
11.9.1 Pharmaxis Company Details
11.9.2 Pharmaxis Business Overview
11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Introduction
11.9.4 Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.9.5 Pharmaxis Recent Development
11.10 ProQR Therapeutics
11.10.1 ProQR Therapeutics Company Details
11.10.2 ProQR Therapeutics Business Overview
11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Introduction
11.10.4 ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.10.5 ProQR Therapeutics Recent Development
11.11 PTC Therapeutics
11.11.1 PTC Therapeutics Company Details
11.11.2 PTC Therapeutics Business Overview
11.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Introduction
11.11.4 PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.11.5 PTC Therapeutics Recent Development
11.12 Alcresta Therapeutics
11.12.1 Alcresta Therapeutics Company Details
11.12.2 Alcresta Therapeutics Business Overview
11.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Introduction
11.12.4 Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.12.5 Alcresta Therapeutics Recent Development
11.13 Insmed Incorporated
11.13.1 Insmed Incorporated Company Details
11.13.2 Insmed Incorporated Business Overview
11.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Introduction
11.13.4 Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.13.5 Insmed Incorporated Recent Development
11.14 Savara
11.14.1 Savara Company Details
11.14.2 Savara Business Overview
11.14.3 Savara Cystic Fibrosis Therapeutics Introduction
11.14.4 Savara Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.14.5 Savara Recent Development
11.15 Cyclacel Pharmaceuticals
11.15.1 Cyclacel Pharmaceuticals Company Details
11.15.2 Cyclacel Pharmaceuticals Business Overview
11.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
11.15.4 Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.15.5 Cyclacel Pharmaceuticals Recent Development
11.16 Vectura
11.16.1 Vectura Company Details
11.16.2 Vectura Business Overview
11.16.3 Vectura Cystic Fibrosis Therapeutics Introduction
11.16.4 Vectura Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.16.5 Vectura Recent Development
11.17 Allergan
11.17.1 Allergan Company Details
11.17.2 Allergan Business Overview
11.17.3 Allergan Cystic Fibrosis Therapeutics Introduction
11.17.4 Allergan Revenue in Cystic Fibrosis Therapeutics Business (2016-2021)
11.17.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CFTR
Table 3. Key Players of Mucolytics
Table 4. Key Players of PERT
Table 5. Key Players of Anti-infectives
Table 6. Key Players of Bronchodilators
Table 7. Global Cystic Fibrosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cystic Fibrosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cystic Fibrosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cystic Fibrosis Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cystic Fibrosis Therapeutics Market Share by Regions (2022-2027)
Table 13. Cystic Fibrosis Therapeutics Market Trends
Table 14. Cystic Fibrosis Therapeutics Market Drivers
Table 15. Cystic Fibrosis Therapeutics Market Challenges
Table 16. Cystic Fibrosis Therapeutics Market Restraints
Table 17. Global Cystic Fibrosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cystic Fibrosis Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis Therapeutics as of 2020)
Table 20. Ranking of Global Top Cystic Fibrosis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cystic Fibrosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cystic Fibrosis Therapeutics Product Solution and Service
Table 24. Date of Enter into Cystic Fibrosis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cystic Fibrosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cystic Fibrosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cystic Fibrosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cystic Fibrosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cystic Fibrosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cystic Fibrosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cystic Fibrosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cystic Fibrosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cystic Fibrosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cystic Fibrosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cystic Fibrosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cystic Fibrosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cystic Fibrosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cystic Fibrosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cystic Fibrosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cystic Fibrosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cystic Fibrosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cystic Fibrosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Vertex Pharmaceuticals Company Details
Table 65. Vertex Pharmaceuticals Business Overview
Table 66. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product
Table 67. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Vertex Pharmaceuticals Recent Development
Table 69. F. Hoffmann-La Roche Company Details
Table 70. F. Hoffmann-La Roche Business Overview
Table 71. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product
Table 72. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 73. F. Hoffmann-La Roche Recent Development
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Cystic Fibrosis Therapeutics Product
Table 77. AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Gilead Sciences Company Details
Table 80. Gilead Sciences Business Overview
Table 81. Gilead Sciences Cystic Fibrosis Therapeutics Product
Table 82. Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Gilead Sciences Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Cystic Fibrosis Therapeutics Product
Table 87. Novartis Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Cystic Fibrosis Therapeutics Product
Table 92. AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. Bayer Company Details
Table 95. Bayer Business Overview
Table 96. Bayer Cystic Fibrosis Therapeutics Product
Table 97. Bayer Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Bayer Recent Development
Table 99. Celtaxsys Company Details
Table 100. Celtaxsys Business Overview
Table 101. Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Celtaxsys Recent Development
Table 103. Pharmaxis Company Details
Table 104. Pharmaxis Business Overview
Table 105. Pharmaxis Cystic Fibrosis Therapeutics Product
Table 106. Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Pharmaxis Recent Development
Table 108. ProQR Therapeutics Company Details
Table 109. ProQR Therapeutics Business Overview
Table 110. ProQR Therapeutics Cystic Fibrosis Therapeutics Product
Table 111. ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 112. ProQR Therapeutics Recent Development
Table 113. PTC Therapeutics Company Details
Table 114. PTC Therapeutics Business Overview
Table 115. PTC Therapeutics Cystic Fibrosis Therapeutics Product
Table 116. PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 117. PTC Therapeutics Recent Development
Table 118. Alcresta Therapeutics Company Details
Table 119. Alcresta Therapeutics Business Overview
Table 120. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product
Table 121. Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 122. Alcresta Therapeutics Recent Development
Table 123. Insmed Incorporated Company Details
Table 124. Insmed Incorporated Business Overview
Table 125. Insmed Incorporated Cystic Fibrosis Therapeutics Product
Table 126. Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 127. Insmed Incorporated Recent Development
Table 128. Savara Company Details
Table 129. Savara Business Overview
Table 130. Savara Cystic Fibrosis Therapeutics Product
Table 131. Savara Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 132. Savara Recent Development
Table 133. Cyclacel Pharmaceuticals Company Details
Table 134. Cyclacel Pharmaceuticals Business Overview
Table 135. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product
Table 136. Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 137. Cyclacel Pharmaceuticals Recent Development
Table 138. Vectura Company Details
Table 139. Vectura Business Overview
Table 140. Vectura Cystic Fibrosis Therapeutics Product
Table 141. Vectura Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 142. Vectura Recent Development
Table 143. Allergan Company Details
Table 144. Allergan Business Overview
Table 145. Allergan Cystic Fibrosis Therapeutics Product
Table 146. Allergan Revenue in Cystic Fibrosis Therapeutics Business (2016-2021) & (US$ Million)
Table 147. Allergan Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. CFTR Features
Figure 3. Mucolytics Features
Figure 4. PERT Features
Figure 5. Anti-infectives Features
Figure 6. Bronchodilators Features
Figure 7. Global Cystic Fibrosis Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Cystic Fibrosis Therapeutics Report Years Considered
Figure 11. Global Cystic Fibrosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cystic Fibrosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cystic Fibrosis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Cystic Fibrosis Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Cystic Fibrosis Therapeutics Market Share by Players in 2020
Figure 16. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cystic Fibrosis Therapeutics Revenue in 2020
Figure 18. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cystic Fibrosis Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Cystic Fibrosis Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Cystic Fibrosis Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cystic Fibrosis Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Cystic Fibrosis Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Cystic Fibrosis Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Region (2016-2027)
Figure 40. China Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cystic Fibrosis Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Cystic Fibrosis Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Cystic Fibrosis Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cystic Fibrosis Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cystic Fibrosis Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cystic Fibrosis Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cystic Fibrosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 62. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 66. Celtaxsys Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 67. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 68. ProQR Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 69. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 70. Alcresta Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 71. Insmed Incorporated Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 72. Savara Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 73. Cyclacel Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 74. Vectura Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 75. Allergan Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, Status and Forecast 2021-2027
QYR2104Z1698 2021年4月 95Pages
QYResearch社発行の本調査資料では、嚢胞性線維症（ムコビスコイドーシス）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胸部理学療法（CPT）、抗生物質消費、肺移植・体位ドレナージ）、用途別市場規模（病院、外来手術センター、その他）...

世界の嚢胞性線維症（CF）治療市場 2021：企業別、地域別、種類・用途別

Global Cystic Fibrosis (CF) Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z04114 2021年4月 104Pages
当調査資料では、嚢胞性線維症（CF）治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。嚢胞性線維症（CF）治療の種類別市場規模（膵臓酵素サプリメント、粘液溶解薬、気管支拡張薬、CFTRモジュレーター）、用途別市場規模（経口薬、吸入薬）、地域別市場規模...

世界の閉経後膣萎縮（PVA）治療薬市場規模・現状・予測（2021年-2027年）

Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4709 2021年4月 93Pages
QYResearch社発行の本調査資料では、閉経後膣萎縮（PVA）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の静脈血栓塞栓症（VTE）治療薬市場規模・現状・予測（2021年-2027年）

Global Venous thromboembolism(VTE)Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5897 2021年4月 98Pages
QYResearch社発行の本調査資料では、静脈血栓塞栓症（VTE）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他）、用途別市場規模（病院、外来手術センター、研究所、その他）、主要地域別...

世界の心的外傷後ストレス障害（PTSD）治療薬市場規模・現状・予測（2021年-2027年）

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4715 2021年4月 99Pages
QYResearch社発行の本調査資料では、心的外傷後ストレス障害（PTSD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のフォンウィルブランド病（VWD）治療薬市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease (VWD) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5967 2021年4月 96Pages
QYResearch社発行の本調査資料では、フォンウィルブランド病（VWD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（デスモプレシン、血栓安定化薬、線維素溶解阻害剤、補充療法、その他）、用途別市場規模（病院薬局、小売薬局、オンライン...

世界の骨髄異形成症候群（MDS）治療薬市場規模・現状・予測（2021年-2027年）

Global Myelodysplastic Syndrome (MDS) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3993 2021年4月 99Pages
QYResearch社発行の本調査資料では、骨髄異形成症候群（MDS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他）、用途別市場規模（入院患者、外来患者）、主要地域別市...

世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年）

Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3935 2021年4月 92Pages
QYResearch社発行の本調査資料では、mRNAがんワクチン・治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん治療用標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途...

世界の水胞性口内炎（VS）治療薬市場規模・現状・予測（2021年-2027年）

Global Vesicular Stomatitis (VS) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5910 2021年4月 90Pages
QYResearch社発行の本調査資料では、水胞性口内炎（VS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（症候性薬、予防接種）、用途別市場規模（獣医病院、獣医クリニック、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の水胞性口内炎（VS）治療薬市場規模・現状・予測（2021年-2027年）

世界の嚢胞性線維症（CF）治療市場 2021：企業別、地域別、種類・用途別 The Cystic Fibrosis (CF) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
世界の嚢胞性線維症（ムコビスコイドーシス）検査市場規模・現状・予測（2021年-2027年） Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thi…
世界の腎線維化治療市場 2021：企業別、地域別、種類・用途別 The Kidney Fibrosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
世界の抗結核治療市場規模・現状・予測（2021年-2027年） Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies. Market Analysis and Insights: Global Anti-tuberculosis Therapeutics Mark…
世界の肺炎治療薬市場規模・現状・予測（2021年-2027年） Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. Market Analysis and…